JP2004513063A5 - - Google Patents

Download PDF

Info

Publication number
JP2004513063A5
JP2004513063A5 JP2000609392A JP2000609392A JP2004513063A5 JP 2004513063 A5 JP2004513063 A5 JP 2004513063A5 JP 2000609392 A JP2000609392 A JP 2000609392A JP 2000609392 A JP2000609392 A JP 2000609392A JP 2004513063 A5 JP2004513063 A5 JP 2004513063A5
Authority
JP
Japan
Prior art keywords
phenyl
carbonyl
ethenyl
sulfide
nitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2000609392A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004513063A (ja
Filing date
Publication date
Priority claimed from US09/541,795 external-priority patent/US6878700B1/en
Application filed filed Critical
Priority claimed from PCT/US2000/008895 external-priority patent/WO2000059880A1/en
Publication of JP2004513063A publication Critical patent/JP2004513063A/ja
Publication of JP2004513063A5 publication Critical patent/JP2004513063A5/ja
Ceased legal-status Critical Current

Links

JP2000609392A 1999-04-02 2000-04-03 細胞接着阻害抗炎症および免疫抑制化合物 Ceased JP2004513063A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28664599A 1999-04-02 1999-04-02
US47451799A 1999-12-29 1999-12-29
US09/541,795 US6878700B1 (en) 1998-12-29 2000-03-31 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
PCT/US2000/008895 WO2000059880A1 (en) 1999-04-02 2000-04-03 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds

Publications (2)

Publication Number Publication Date
JP2004513063A JP2004513063A (ja) 2004-04-30
JP2004513063A5 true JP2004513063A5 (https=) 2006-05-11

Family

ID=26963975

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000609392A Ceased JP2004513063A (ja) 1999-04-02 2000-04-03 細胞接着阻害抗炎症および免疫抑制化合物

Country Status (27)

Country Link
EP (2) EP1165505B1 (https=)
JP (1) JP2004513063A (https=)
KR (1) KR100678999B1 (https=)
CN (1) CN1353691A (https=)
AT (1) ATE275543T1 (https=)
AU (2) AU774564B2 (https=)
BG (1) BG106029A (https=)
BR (1) BR0009426A (https=)
CA (1) CA2369238A1 (https=)
CZ (1) CZ296856B6 (https=)
DE (1) DE60013575T2 (https=)
EA (2) EA005563B1 (https=)
EE (1) EE200100513A (https=)
GE (1) GEP20053657B (https=)
HK (1) HK1045146A1 (https=)
HR (1) HRP20010776B1 (https=)
HU (1) HUP0202031A2 (https=)
IL (2) IL145529A0 (https=)
IS (2) IS2125B (https=)
MX (1) MXPA01009766A (https=)
NO (1) NO20014767L (https=)
NZ (1) NZ515237A (https=)
PL (1) PL352018A1 (https=)
SK (1) SK14012001A3 (https=)
UA (1) UA74781C2 (https=)
WO (1) WO2000059880A1 (https=)
ZA (1) ZA200108944B (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051084A1 (en) * 2000-01-14 2001-07-19 Genentech, Inc. Diagnosis and treatment of hepatic inflammatory disorders by inhibiting the binding of lfa-1 to icam-1
NZ523445A (en) 2000-06-29 2004-10-29 Abbott Lab Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
PE20020354A1 (es) 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
WO2002051805A1 (de) * 2000-12-27 2002-07-04 Bayer Aktiengesellschaft Indol-derivate
NZ539682A (en) * 2001-01-29 2006-03-31 Dimensional Pharm Inc Substituted indoles and their use as integrin antagonists
WO2002070478A1 (en) 2001-03-06 2002-09-12 Astrazeneca Ab Indolone derivatives having vascular-damaging activity
FR2829766A1 (fr) * 2001-09-14 2003-03-21 Lipha Derives d'oxamates comportant un heterocycle azote diversement substitue
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
EP1444981A1 (en) 2001-10-11 2004-08-11 Katsuhiko Mikoshiba Intracellular calcium concentration increase inhibitors
NZ563604A (en) * 2001-11-29 2009-04-30 Theracos Inc Compounds for treatment of inflammation, diabetes and related disorders
US7101898B2 (en) 2002-02-01 2006-09-05 Novo Nordisk A/S Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
AU2003203143B2 (en) * 2002-02-01 2009-05-14 High Point Pharmaceuticals, Llc Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
KR101011373B1 (ko) 2002-07-11 2011-01-28 비큐론 파마슈티컬스 인코포레이티드 항균작용을 갖는 n-히드록시아미드 유도체
WO2004032861A2 (en) 2002-10-11 2004-04-22 Bristol-Myers Squibb Company Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
WO2005019177A1 (en) * 2003-08-14 2005-03-03 Icos Corporation Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof
JP2007535555A (ja) * 2004-04-28 2007-12-06 イコス・コーポレイション 炎症性疾患および免疫疾患の処置に有用なアリールフェニルアミノ−およびアリールフェニルエーテル−スルフィド誘導体、およびそれらを含む医薬組成物
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
TW200616634A (en) 2004-10-01 2006-06-01 Bristol Myers Squibb Co Crystalline forms and process for preparing spiro-hydantoin compounds
US7186727B2 (en) 2004-12-14 2007-03-06 Bristol-Myers Squibb Company Pyridyl-substituted spiro-hydantoin compounds and use thereof
AU2006206410B2 (en) 2005-01-20 2012-08-30 Ampio Pharmaceuticals, Inc. Methylphenidate derivatives and uses of them
ZA200803939B (en) * 2005-11-24 2009-10-28 Eisai R&D Man Co Ltd Morpholine type cinnamide compound
TW200831080A (en) * 2006-12-15 2008-08-01 Irm Llc Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
EP2300011A4 (en) 2008-05-27 2012-06-20 Dmi Life Sciences Inc THERAPEUTIC PROCESSES AND COMPOUNDS
US20140072584A1 (en) * 2010-12-08 2014-03-13 Xianliang Li Novel pharmaceutical use of benzoic acid derivatives
JP6784069B2 (ja) * 2015-07-07 2020-11-11 Jnc株式会社 液晶性化合物、液晶組成物および液晶表示素子
WO2018191146A1 (en) 2017-04-10 2018-10-18 Navitor Pharmaceuticals, Inc. Heteroaryl rheb inhibitors and uses thereof
AU2018366022B2 (en) * 2017-11-07 2024-05-16 The Regents Of The University Of Michigan Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208253A (en) * 1992-02-24 1993-05-04 Warner-Lambert Company 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo(b) thiophene-2-carboxamides as inhibitors of cell adhesion
US5734081A (en) * 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
JP2002501518A (ja) * 1997-05-30 2002-01-15 セルテック セラピューティックス リミテッド 抗炎症性チロシン誘導体
US6110922A (en) * 1998-12-29 2000-08-29 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds

Similar Documents

Publication Publication Date Title
JP2004513063A5 (https=)
CN1993339B (zh) 芳香化合物
CA2293382C (en) Piperazine derivatives and their use as anti-inflammatory agents
JP2004532886A5 (https=)
CA2463272C (en) Piperazine derivatives with ccr1 receptor antagonist activity
JP5089185B2 (ja) コラーゲン産生抑制剤。
CA2356320C (en) Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
NO302473B1 (no) Pyrimidinderivater
CA2369238A1 (en) Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
JP2000504677A (ja) 5ht7レセプター・アンタゴニスト用のスルホンアミド誘導体
JP4309251B2 (ja) システインプロテアーゼの可逆的阻害剤として有効な新規なニトリル
MX2008015696A (es) Acidos fenil aceticos sustituidos como antagonistas de dp-2.
CA2498261A1 (en) Use of piperazine derivatives as ccr1 antagonists
RU97113374A (ru) Производные 4-гидроксипиперидина
US7091202B2 (en) 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators
DE60316683T2 (de) Phenylcyclohexylpropanolaminderivate, deren herstellung und therapeutsche anwendung
JP4880678B2 (ja) 肝臓のカルニチンパルミトイルトランスフェラーゼ(l−cpt1)阻害剤として有用なスルホンアミド誘導体
US7605159B2 (en) Cathepsin cysteine protease inhibitors and their use
US5728835A (en) Substituted cyclic amine compound, production process thereof and pharmaceutical composition for circulatory organ use containing the same
JP2001502348A (ja) 金属タンパク質分解酵素阻害剤
ES2715394T3 (es) Nuevo antifúngico derivado de oxodihidropiridinacarbohidrazida
CZ280337B6 (cs) Estery kyseliny dusičné s deriváty cyklohexanolu
US20050250768A1 (en) Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
JP2000204079A (ja) ジアリ―ルアミン
ES2368153T3 (es) Nuevo compuesto cíclico que presenta un grupo 4-piridilalquiltio que presenta amino (no) sustituido introducido en el mismo.